A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Tedeschi, A; Greil, R; Demirkan, F; Robak, T; Moreno, C; Barr, PM; Anz, B; Simpson, D; Gaidano, G; Bairey, O; Stevens, D; Gill, D; Flinn, IW; Kipps, TJ; Burger, JA; Lin, J; Webb, T; Fedorov, V; Styles, L; Gribben, JG

Citations

Scopus

Altmetric

Author

Tedeschi, A; Greil, R; Demirkan, F; Robak, T; Moreno, C; Barr, PM; Anz, B; Simpson, D; Gaidano, G; Bairey, O; ...

Date

2020-04

Source Title

Haematologica: the hematology journal

Publisher

Ferrata Storti Foundation (Haematologica)

University of Melbourne Author/s

Simpson, David

Affiliation

School of Physics

Metadata

Show full item record

Document Type

Journal Article

Citations

Tedeschi, A., Greil, R., Demirkan, F., Robak, T., Moreno, C., Barr, P. M., Anz, B., Simpson, D., Gaidano, G., Bairey, O., Stevens, D., Gill, D., Flinn, I. W., Kipps, T. J., Burger, J. A., Lin, J., Webb, T., Fedorov, V., Styles, L. & Gribben, J. G. (2020). A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.. Haematologica, 105 (4), pp.e164-e168. https://doi.org/10.3324/haematol.2019.223743.

Access Status

Access this item via the Open Access location